Literature DB >> 33121322

Pertussis in Italy: how to protect the "unprotectable"?

Fabiana Fiasca1, Stefano Necozione1, Antonella Mattei1.   

Abstract

Whooping cough continues to be an important public health issue despite high levels of vaccination coverage with acellular pertussis vaccine. Young unimmunized infants represent the most vulnerable group with the highest rates of complications and death. As infant-specific pertussis epidemiologic data, especially among neonates, in Italy were limited, a retrospective observational study of hospitalizations for whooping cough in Italian infants aged <12 months between 2007 and 2018 was conducted to address this knowledge gap. The temporal trend of rates, also stratified for age classes according to the expected age for the administration of vaccine doses, were analyzed by the slope of the regression line. The mean age at the time of admission was 92 d (±64). A clear seasonal pattern in the occurrence of pertussis hospitalizations with a summer peak was observed. Infants younger than 3 months old had the highest hospitalization rates (169 x 100000 infants on average), with a significant rising trend of 9 x 100000 infants on average per year. Limiting the analysis to Bordetella pertussis-related hospitalizations such trend was even more evident. In the other age classes, hospitalization rates were considerably lower and gradually decreased with increasing age. This study demonstrated that pediatric populations, too young to be protected by vaccination, had a greater risk of contracting pertussis. Thus, it is necessary to promote additional immunization strategies besides one booster dose in adolescents, including vaccination during pregnancy.

Entities:  

Keywords:  Pertussis; infants; pregnancy; vaccine; whooping cough

Year:  2020        PMID: 33121322      PMCID: PMC8018419          DOI: 10.1080/21645515.2020.1806673

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  26 in total

1.  Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial.

Authors:  J Storsaeter; H Hallander; C P Farrington; P Olin; R Möllby; E Miller
Journal:  Vaccine       Date:  1990-10       Impact factor: 3.641

2.  Comparison of pertussis surveillance systems in Europe.

Authors:  Alberto E Tozzi; Elisabetta Pandolfi; Lucia Pastore Celentano; Marco Massari; Stefania Salmaso; Marta L Ciofi degli Atti
Journal:  Vaccine       Date:  2006-08-02       Impact factor: 3.641

3.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-10-21       Impact factor: 17.586

4.  Pertussis in infants and the resurgence of a vaccine preventable disease: what to do? Commentary.

Authors:  Giorgio Fedele; Paola Stefanelli
Journal:  Ann Ist Super Sanita       Date:  2017 Apr-Jun       Impact factor: 1.663

Review 5.  Strategies to decrease pertussis transmission to infants.

Authors:  Kevin Forsyth; Stanley Plotkin; Tina Tan; Carl Heinz Wirsing von König
Journal:  Pediatrics       Date:  2015-05-11       Impact factor: 7.124

6.  Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.

Authors:  Marie-Louise von Linstow; Peter Lotko Pontoppidan; Carl-Heinz Wirsing von König; James D Cherry; Birthe Hogh
Journal:  Eur J Pediatr       Date:  2010-04-08       Impact factor: 3.183

7.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

8.  Bordetella pertussis in infants hospitalized for acute respiratory symptoms remains a concern.

Authors:  Ambra Nicolai; Raffaella Nenna; Paola Stefanelli; Anna Carannante; Concetta Schiavariello; Alessandra Pierangeli; Carolina Scagnolari; Corrado Moretti; Paola Papoff; Enea Bonci; Marianna Ferrara; Stefano Papasso; Fabio Midulla
Journal:  BMC Infect Dis       Date:  2013-11-08       Impact factor: 3.090

9.  Pertussis in Young Infants Throughout the World.

Authors:  James D Cherry
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

10.  Measles-Related Hospitalizations in Italy, 2004-2016: The Importance of High Vaccination Coverage.

Authors:  Fabiana Fiasca; Stefano Necozione; Leila Fabiani; Marianna Mastrodomenico; Antonella Mattei
Journal:  Ann Glob Health       Date:  2019-03-19       Impact factor: 2.462

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.